Chrysavgi Lalayanni
Thessaloniki, ESYE12, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Ravulizumab for treatment of paroxysmal nocturnal hemoglobinuria during pregnancy.
Journal: Blood advances
Published: December 01, 2025
Ravulizumab for Treatment of Paroxysmal Nocturnal Hemoglobinuria During Pregnancy.
Journal: Blood advances
Published: December 01, 2025
Treosulfan-Based Conditioning Regimens for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia and Other Myeloid Malignancies.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 24, 2025
PFS24 as a prognostic milestone in patients with newly diagnosed primary CNS lymphoma.
Journal: Journal of hematology & oncology
Published: February 10, 2025
The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodes.
Journal: American journal of hematology
Published: June 07, 2024
Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data.
Journal: Frontiers in medicine
Published: May 20, 2023
Thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): Real world data of a Greek nationwide multicenter retrospective study.
Journal: Frontiers in oncology
Published: December 21, 2022
Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories.
Journal: Frontiers in oncology
Published: December 13, 2022
Adolescents and young adults (AYA) with acute myeloid leukemia (AML): real-world long-term results and age-specific outcomes.
Journal: Leukemia & lymphoma
Published: August 24, 2022
Last Updated: 09/26/2026